Medication Adherence in Children Who Had a Liver Transplant (MALT)

接受肝移植 (MALT) 的儿童的药物依从性

基本信息

  • 批准号:
    8702150
  • 负责人:
  • 金额:
    $ 55.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-12-22 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This revised multi-center proposal takes advantage of the existing Studies in Pediatric Liver Transplant (SPLIT) registry augmented by additional prospectively-obtained data to test an objective measure of adherence to immunosuppressant medications in children who had a liver transplant. Nonadherence is the most important reason for organ rejection in long term survivors of pediatric liver transplantation. In order to address this important risk-factor effectively, the first step is to evaluate a method that would identify nonadherence in these children. Medication blood levels that are obtained as a part of clinical practice in transplant centers can be used to determine whether the patient is adherent or not. Calculating the degree of fluctuation of medication blood levels over time for each patient would identify nonadherence (more fluctuation = less consistent medication-taking = less adherence). The degree of fluctuation in medication blood levels is correlated with rejection episodes. This grant evaluates the use of this method (calculating the variability in medication blood levels) along with other ancillary measures of adherence in a large group of transplant patients. It determines a "threshold" of adherence (when does nonadherence begin to be associated with organ rejection). This proposal also takes advantage of the prospectively-followed cohort to evaluate psychosocial predictors for nonadherence. Those predictors can be used to inform intervention efforts to improve adherence. Since this proposal will validate a clinically- useful method to assess adherence, the results are expected to enhance survival and reduce rejections in pediatric transplant recipients. Results are also expected to inform adherence research in other fields: the novel, objective, biological marker for nonadherence can be used in other populations. Furthermore, the detection method will provide the essential basis to support adherence research in the transplant setting (such as treatment strategies), results from which can be generalized to other settings. PUBLIC HEALTH RELEVANCE: The survival of children who have received an organ transplant is dependent on immunosuppressant medications, but many stop taking them. This proposal will validate a method to identify children who are at risk because of not taking their medications. The results will help transplant centers identify these children and improve overall post transplant survival, and will also inform other areas of medicine in which children may not take their medications as prescribed.
描述(由申请人提供):本修订后的多中心提案利用了现有的儿童肝移植研究(SPLIT)注册表,并辅以额外的前瞻性数据,以测试接受肝移植的儿童对免疫抑制药物依从性的客观测量。不依从性是儿童肝移植长期存活者器官排斥的最重要原因。为了有效地解决这一重要的风险因素,第一步是评估一种方法来识别这些儿童的不依从性。作为移植中心临床实践的一部分,获得的药物血液水平可用于确定患者是否坚持。计算每位患者血液中药物水平随时间的波动程度,可以识别出不依从性(波动越大=服药越不一致=依从性越差)。药物血药浓度的波动程度与排斥反应有关。该资助评估了该方法(计算药物血液水平的可变性)以及其他辅助依从性措施在一大群移植患者中的使用情况。它决定了依从性的“阈值”(不依从性何时开始与器官排斥有关)。本建议还利用前瞻性随访队列来评估不依从的心理社会预测因素。这些预测因素可用于告知干预措施,以提高依从性。由于该建议将验证一种临床有用的方法来评估依从性,结果有望提高儿童移植受者的生存率并减少排斥反应。结果也有望为其他领域的依从性研究提供信息:这种新的、客观的、不依从性的生物标记物可以用于其他人群。此外,检测方法将为支持移植环境中的依从性研究(如治疗策略)提供必要的基础,其结果可以推广到其他环境。公共卫生相关性:接受器官移植的儿童的生存依赖于免疫抑制药物,但许多人停止服用它们。该提案将验证一种方法,以识别因未服用药物而处于危险中的儿童。结果将有助于移植中心识别这些儿童,提高移植后的总体存活率,也将为其他可能不按规定服药的儿童提供信息。

项目成果

期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Medication level variability index predicts rejection, possibly due to nonadherence, in adult liver transplant recipients.
  • DOI:
    10.1002/lt.23930
  • 发表时间:
    2014-10
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Supelana, Christina;Annunziato, Rachel A.;Schiano, Thomas D.;Anand, Ravinder;Vaidya, Swapna;Chuang, Kelley;Zack, Yelena;Florman, Sander;Shneider, Benjamin L.;Shemesh, Eyal
  • 通讯作者:
    Shemesh, Eyal
The Medication Level Variability Index (MLVI) Predicts Poor Liver Transplant Outcomes: A Prospective Multi-Site Study.
Adherence to medical recommendations and transition to adult services in pediatric transplant recipients.
  • DOI:
    10.1097/mot.0b013e32833984a5
  • 发表时间:
    2010-06
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Shemesh E;Annunziato RA;Arnon R;Miloh T;Kerkar N
  • 通讯作者:
    Kerkar N
Assessment and management of psychosocial challenges in pediatric liver transplantation.
儿科肝移植中心理社会挑战的评估和管理。
The Utility of a Pre-Transplant Psychosocial Evaluation in Predicting Post-Liver Transplant Outcomes.
  • DOI:
    10.1177/1526924820978605
  • 发表时间:
    2021-03
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Becker JH;Shemesh E;Shenoy A;Posillico A;Knight CS;Kim SK;Florman SS;Schiano T;Annunziato RA
  • 通讯作者:
    Annunziato RA
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EYAL SHEMESH其他文献

EYAL SHEMESH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EYAL SHEMESH', 18)}}的其他基金

Improving Medication Adherence in adolescents who had a Liver Transplant: iMALT
改善接受肝移植的青少年的药物依从性:iMALT
  • 批准号:
    9788434
  • 财政年份:
    2018
  • 资助金额:
    $ 55.3万
  • 项目类别:
Improving Medication Adherence in adolescents who had a Liver Transplant: iMALT
改善接受肝移植的青少年的药物依从性:iMALT
  • 批准号:
    10891339
  • 财政年份:
    2018
  • 资助金额:
    $ 55.3万
  • 项目类别:
Improving Medication Adherence in adolescents who had a Liver Transplant: iMALT
改善接受肝移植的青少年的药物依从性:iMALT
  • 批准号:
    10255996
  • 财政年份:
    2018
  • 资助金额:
    $ 55.3万
  • 项目类别:
Improving Medication Adherence in adolescents who had a Liver Transplant: iMALT
改善接受肝移植的青少年的药物依从性:iMALT
  • 批准号:
    10021643
  • 财政年份:
    2018
  • 资助金额:
    $ 55.3万
  • 项目类别:
Improving Medication Adherence in adolescents who had a Liver Transplant: iMALT
改善接受肝移植的青少年的药物依从性:iMALT
  • 批准号:
    10466911
  • 财政年份:
    2018
  • 资助金额:
    $ 55.3万
  • 项目类别:
Improving Medication Adherence in adolescents who had a Liver Transplant: iMALT
改善接受肝移植的青少年的药物依从性:iMALT
  • 批准号:
    10018172
  • 财政年份:
    2018
  • 资助金额:
    $ 55.3万
  • 项目类别:
Improving Medication Adherence in children who had a Liver Transplant: iMALT
提高肝移植儿童的药物依从性:iMALT
  • 批准号:
    9263382
  • 财政年份:
    2016
  • 资助金额:
    $ 55.3万
  • 项目类别:
Improving Medication Adherence in children who had a Liver Transplant: iMALT
提高肝移植儿童的药物依从性:iMALT
  • 批准号:
    9352316
  • 财政年份:
    2016
  • 资助金额:
    $ 55.3万
  • 项目类别:
Medication Adherence in Children Who Had a Liver Transplant (MALT)
接受肝移植 (MALT) 的儿童的药物依从性
  • 批准号:
    8023936
  • 财政年份:
    2009
  • 资助金额:
    $ 55.3万
  • 项目类别:
Medication Adherence in Children Who Had a Liver Transplant (MALT)
接受肝移植 (MALT) 的儿童的药物依从性
  • 批准号:
    8293366
  • 财政年份:
    2009
  • 资助金额:
    $ 55.3万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.3万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 55.3万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.3万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.3万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.3万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.3万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 55.3万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 55.3万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 55.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 55.3万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了